The Clorazepate Dipotassium Capsules, cataloged under National Stock Number 6505-01-015-2184, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Abbott Laboratories Pharmaceutical Products Div. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-015-2184 |
| Primary Part Number | NDC00074-3417-53 |
| Item Name | Clorazepate Dipotassium Capsules |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Abbott Laboratories Pharmaceutical Products Div |
| Status | ACTIVE |
| Primary Container Type | BOTTLE |
| Capsule Primary Container Content Quantity | 500.000 |
| Active Medicament Medicinal Strength | 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00074-3417-53 PRIMARY | Abbott Laboratories Pharmaceutical Products Div (USA) |
| Reference | Meaning |
|---|---|
| TRANXENE CAPSULES | 5/1 Secondary reference Abbott Laboratories Pharmaceutical Products Div |
NSN 6505-01-015-2184 is a Clorazepate Dipotassium Capsules, manufactured by Abbott Laboratories Pharmaceutical Products Div, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-015-2184 has 1 manufacturer part number on file: NDC00074-3417-53 (Abbott Laboratories Pharmaceutical Products Div).
Key specifications for NDC00074-3417-53: Primary Container Type: BOTTLE; Capsule Primary Container Content Quantity: 500.000; Active Medicament Medicinal Strength: 3.750 MILLIGRAMS CLORAZEPATE DIPOTASSIUM ACTIVE INGREDIENT. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.